Member Info for Benharper

Out with the Jumper on with the blouse, how very modern, wonder if he’ll premiere this new look with Paul Hill tomorrow.

So he’s got optionality in his manner of departure?

Is Fiona’s role available for Al to sidestep into?

My question still stands though.

There is dilution but there won’t be a big float of retail shares flying about

Genuine question Wyn. Was the price agreed weeks ago? Or was the discount percentage agreed weeks ago?

Yep I get what you’re saying Timster 2 weekly reading out on time, despite little communication regarding it even starting.

What is the dose expansion phase? Is that new?

Poster or oral is the question?

Could be, it also could be a short attack initiated for a low entry for some, we shall see

If it’s an open offer at this price then there better be a decent explanation..

The logic for a placing is that thought eggy. You’ve got to ask the question if they are going for it now, why? Is it cause they want the sticky II protection for data and deals inbound to guard against a low ball offer? They are cashed up to the back end of the year, perhaps the company needs this protection sooner?

The logic is for a placing with a sticky handed II is to protect against future lowball offers and fund p2.

Results could be so good that the attitude is just crack on, we’ll sort out various dosing levels and intervals further down the road. The FDA seem quite proactive when it comes to saving lives, and this is what this is all about. Anyhow, not what I think will happen, but it could

So if we’re going to go down the avenue of ‘ifs’, what if the results on first line patients in C7 have been so good that the fortnightly dosing has been scrapped and it’s straight into P2? Might explain the need for funding but ‘if’ that news drops where would that leave the shorting crew!!

They might bring healthcare investors onboard before releasing game changing data and license deals. They get in cheap. We get protection from lowball offers, but also, once data and deals land, share price can appreciate as funding is also secured

Obviously this guys a troll, but when our own brokers still only give Ava6000 a 10% cos, it is a bit frustrating

Do bear in mind the bears are mostly one person having a conversation with themselves

It would depend entirely on what the product was, you’d be an utter fool to base your decision to negotiate or not with a company based on how they funded their operations

The funding is required for p2 and ava3996 ind, and ongoing general business costs. They have funding until the back end of this year. It’s probably also wise to have a decent balance sheet whilst negotiating license deals for your tech with other companies to avoid lowball deal offers. There isn’t a panic as yet but as the company have said they are always considering their options. I personally feel an II to firm up the share register so when data drops we are funded and protected from low ball takeover offers.

What new parallel universe is this all about? Beyond fud. I admire the fantasy aspects of it, very imaginative.